Prerequisites
- Master degree or equivalent in molecular and cellular biology, genetics / epigenetics, biotechnology, biostatistics / mathematics
- Fluency in English
- Candidates from any country are welcome and women and minority students are encouraged to apply.
How to apply
To apply, please fill out the enclosed application form (click here) and send it, together with a motivation letter, CV and copies of academic degree, as a single PDF file, to: magali.frainier@epfl.ch ; in addition please forward the enclosed evaluation form (click here) to 2-3 referees familiar with your studies and previous research experience, including your previous direct advisor(s).
Deadline
December 15 2019
Selection procedure
The CancerPrev selection committee, composed of the participating PIs, will review and rank all applications and candidates passing the first round of selection will be invited for an oral interview, either by Skype or in person. At that time, they will be asked by the interviewers to prepare a short written document on a paper / topic of relevance to their projected future work.
Starting dates are flexible, earliest date is March 1st 2019.
This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 859860